Healthcare organizations will need to test models in their local environments, keep an eye on performance and work together to implement the technology, panelists said at HLTH.
Thoughtful implementation, ongoing monitoring key to safe health AI Read More »
The acquisition of Aliada Therapeutics gives AbbVie access to a Phase I anti-amyloid antibody as well as the biotech’s novel platform engineered for efficient blood-brain barrier transport.
AbbVie Doubles Down on Alzheimer’s With $1.4B Aliada Buy Read More »
The Swiss pharma is paying $150 million upfront to gain rights to Monte Rosa’s VAV1-targeting molecular glue degraders, led by a Phase I candidate which holds therapeutic promise for immune-mediated diseases.
Novartis Inks Potential $2.2B Molecular Glue Deal With Monte Rosa Read More »
Laboratories face a series of upcoming deadlines to comply with stricter FDA oversight of in-house tests. Here are five strategies labs can take to be ready.
5 steps to navigate the FDA’s new lab developed test rule Read More »
Orlynvah is the first oral penem approved in the U.S. and Iterum Therapeutics’ first FDA-approved product. CEO Corey Fishman said the company will renew its efforts to look for a potential partner to maximize value for its stakeholders.
Jefferies analyst Kelly Shi in a Sunday note to investors said that both data drops for Revolution Medicines’ experimental RAS inhibitors are positive for the two promising assets in pancreatic ductal adenocarcinoma, which could be “synergistic” in the first-line setting based on preclinical combination data.
William Blair analyst Myles Minter in a Monday note to investors said that Vertex’s povetacicept “has maintained its potential to be a best-in-class asset” in the IgA nephropathy space and could become a “multibillion-dollar pipeline-in-a-drug product” for autoimmune disorders, while “outstanding questions” remain for Biogen’s felzartamab before moving into pivotal studies.
Biogen, Vertex Heat Up IgAN Arena With Mid-Stage Readouts at ASN 2024 Read More »
¿Hasta qué punto vacunar contra la gripe a menores de 5 años es acertado? Un nuevo estudio ha examinado esta cuestión. Los autores del estudio se centraron en el caso de España. En octubre de 2023, se recomendó por primera vez a nivel estatal en Esp …
La Saga de Sverre, un texto escrito entre finales del siglo XII y principios del XIII narra una serie de sucesos en torno al rey Sverre Sigurdsson, monarca de Noruega en aquella época. Aunque, como en otros muchos casos parecidos, existen dudas sobre la veracidad de algunas de las cosas relat …
El misterioso hombre arrojado a un pozo hace 800 años Read More »
Arthur C. Clarke fue un escritor, inventor y futurista británico cuya obra transformó la ciencia ficción y predijo desarrollos tecnológicos que hoy en día son una realidad. Conocido por su novela “2001: Una odisea del espacio”, Clarke no solo fue un narra …
Arthur C. Clarke: Visionario de la ciencia ficción y la ciencia del futuro Read More »
